RxDoctor Payments Data
★ My doctorsLook up a doctor →

Adrian Murphy

Medical Oncology · Baltimore, MDNPI 1427497551

Payments from drug & device makers

$375,937in general payments, 2019–2025

Across 206 payments — averaging $1824.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$182K
  • AstraZeneca$120K
  • Agios Pharmaceuticals, Inc.$53K
  • Halozyme Inc$15K
  • E.r. Squibb & Sons, L.L.C.$5K
  • Servier Pharmaceuticals LLC$2K
  • plus $48 from 2 others
$900in research payments, 2019–2025

Across 1 payment — averaging $900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$900

What the payments were for

  • Speaking & faculty fees$1,97196%
  • Food & beverage$724%

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Incyte Corporation145$182,036
AstraZeneca1$119,787
Agios Pharmaceuticals, Inc.26$52,578
Halozyme Inc28$14,915
E.r. Squibb & Sons, L.L.C.2$4,602
Servier Pharmaceuticals LLC2$1,971
Eli Lilly1$37
Genentech, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$375,937 in reported general payments places this provider in the 60th percentile of 180 medical oncology providers in Maryland.

See all medical oncology providers in Maryland →

Other medical oncology in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →